Apr. 23 at 12:08 AM
$NXTC 🔬 Research Achievements
As a lead investigator, he has managed numerous projects funded by the National Natural Science Foundation of China, the Shanghai Municipal Science and Technology Commission, and various medical leadership talent funds. He has also contributed to major national initiatives like the 863 Program.
His academic impact includes:
141 published papers, with over 80 SCI-indexed articles.
Key findings published in Annals of Oncology, Clinical Cancer Research, Oncogene, and Gynecologic Oncology.
Multiple accolades, including first and second prizes from the Shanghai Anti-Cancer Association Science and Technology Awards.
Primary Research Interests:
Genetic susceptibility, targeted therapy, and resistance mechanisms in ovarian cancer.
Laparoscopic preoperative assessment for advanced ovarian cancer.
Postoperative consolidation and maintenance therapy for ovarian cancer.
